The Christie NHS Foundation

The trials here

What the 3 trials at this site are about, from their registry records.

Conditions

• Liver and biliary tract cancer1 trial
• Lung cancer1 trial
• Pancreatic cancer1 trial

Phase

• Phase 32 trials
• Phase 21 trial

Status

• Recruiting2 trials
• Active, not recruiting1 trial

Lead sponsor

• Elevar Therapeutics1 trial
• Gilead Sciences1 trial
• Immuneering Corporation1 trial

Running trials

• Recruiting

  Atebimetinib + GnP as a First Line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma

  NCT07562152· Phase 3· Immuneering Corporation· Source

  Contact: Jessica Jones

• Recruiting

  A Study of Lirafugratinib in Non-CCA Solid Tumors With FGFR2 Fusion or Rearrangement

  NCT07359820· Phase 2· Elevar Therapeutics· Source

  Contact: James Weaver, MD (principal investigator)

• Active, not recruiting

  Study of Sacituzumab Govitecan (SG) Versus Docetaxel in Participants With Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)

  NCT05089734· Phase 3· Gilead Sciences· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Liver and biliary tract cancer1 recruiting
• Pancreatic cancer1 recruiting